loadpatents
name:-0.0079681873321533
name:-0.0067529678344727
name:-0.0012428760528564
Nam; Tae-gyu Patent Filings

Nam; Tae-gyu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nam; Tae-gyu.The latest application filed is for "pyridinol derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient".

Company Profile
1.7.8
  • Nam; Tae-gyu - Suwon-si KR
  • Nam; Tae gyu - Gyeonggi-do KR
  • NAM; Tae Gyu - Suwon KR
  • Nam; Tae-Gyu - Chungbuk KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyridinol derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient
Grant 10,604,487 - Jeong , et al.
2020-03-31
Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
Grant 10,544,140 - Jeong , et al. Ja
2020-01-28
Pyridinol Derivative Or Pharmaceutically Acceptable Salt Thereof, And Pharmaceutical Composition Containing Same As Active Ingredient
App 20190010125 - JEONG; Byeong-Seon ;   et al.
2019-01-10
Pharmaceutical Composition Containing, As Active Ingredient, 7-azaindolin-2-one Derivative Or Pharmaceutically Acceptable Salt Thereof
App 20180370964 - JEONG; Byeong-Seon ;   et al.
2018-12-27
Method of treating inflammatory bowel disease comprising administering a pharmaceutical composition comprising a 6-aminopyridin-3-ol compound or a pharmaceutically acceptable salt thereof as an active ingredient to a subject
Grant 9,889,139 - Jeong , et al. February 13, 2
2018-02-13
Amidopyridinol derivative or pharmaceutically acceptable salt thereof and pharmaceutical composition comprising same as active component
Grant 9,802,897 - Jeong , et al. October 31, 2
2017-10-31
Method Of Treating Inflammatory Bowel Disease Comprising Administering A Pharmaceutical Composition Comprising A 6-aminopyridin-3-ol Compound Or A Pharmaceutically Acceptable Salt Thereof As An Active Ingredient To A Subject
App 20160354352 - JEONG; Byeong Seon ;   et al.
2016-12-08
Pharmaceutical composition comprising bicyclic pyridinol derivatives for preventing or treating diseases caused by angiogenesis
Grant 9,505,757 - Jeong , et al. November 29, 2
2016-11-29
6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis
Grant 9,452,159 - Jeong , et al. September 27, 2
2016-09-27
Amidopyridinol Derivative Or Pharmaceutically Acceptable Salt Thereof And Pharmaceutical Composition Comprising Same As Active Component
App 20160068489 - JEONG; Byeong Seon ;   et al.
2016-03-10
Pharmaceutical Composition Comprising Bicyclic Pyridinol Derivatives For Preventing Or Treating Diseases Caused By Angiogenesis
App 20150320729 - JEONG; Byeong Seon ;   et al.
2015-11-12
6-aminopyridine-3-ol Derivatives Or Pharmaceutically Acceptable Salts Thereof, And Pharmaceutical Composition Containing Same As Active Ingredients For Preventing Or Treating Diseases Caused By Angiogenesis
App 20150238471 - Jeong; Byeong Seon ;   et al.
2015-08-27
Pharmaceutical Composition Comprising Bicyclic Pyridinol Derivatives For Preventing Or Treating Diseases Caused By Angiogenesis
App 20150031890 - Jeong; Byeong Seon ;   et al.
2015-01-29
Asiatic acid derivatives its manufacturing method and dermatological agent containing it
Grant 5,834,437 - Jew , et al. November 10, 1
1998-11-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed